DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Sanchez-Tapias JM, Diago M, Escartin P et al.
Peginterferon-alfa2a plus ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment.
Gastroenterology 2006;
131: 451-460
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.